(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Thursday said the drugs Enhertu and Datroway received new approvals for breast cancer treatment applications in China. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
(Alliance News) - AstraZeneca PLC on Monday announced the opening of its newest global strategic research and development centre, in Massachusetts. Read More
AstraZeneca PLC - Cambridge, England-based pharmaceutical company - Says it has successfully completed its USD2 billion equity investment in Summit Therapeutics. The funding will accelerate the development of first-in-class bispecific antibody ivonescimab, which targets PD-1 and VEGF across multiple tumour types in combination with antibody-drug conjugates. Notes that it has also entered a clinical collaboration agreement with Summit to evaluate sonesitatug vedotin in combination with ivonescimab. They also intend to enter an additional deal, which would initiate a global development programme combining other AstraZeneca cancer medicines. Read More
(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Friday said they entered into a clinical trial collaboration with the biopharmaceutical oncology company Summit Therapeutics Inc to evaluate the use of Datroway in combination with ivonescimab in treating multiple tumour types. Read More
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More
(Alliance News) - Hutchmed China Ltd on Tuesday said AstraZeneca PLC submitted a new drug application to the US Food & Drug Administration for Orpathys, or savolitinib, in combination with Tagrisso for patients with non-small cell lung cancer. Read More
(Alliance News) - Stock prices in London opened higher on Tuesday, as pharmaceutical and mining stocks advanced, while oil prices eased amid signs of progress towards renewed talks between the US and Iran. Read More
(Alliance News) - AstraZeneca submits a US regulatory application for a lung cancer treatment developed with Hutchmed. Close Brothers reports a narrowed annual loss but withholds its dividend amid motor finance uncertainty, while Zigup raises its annual profit expectations after a strong start to the year. Read More
(Alliance News) - Stock prices in London were higher at midday on Friday as hopes for progress towards reopening the Strait of Hormuz pushed oil prices lower, although Brent stayed above USD100, while global bond yields remained elevated. Read More
(Alliance News) - AstraZeneca PLC on Friday said the US Food & Drug Administration granted priority review for its human monoclonal antibody Imfinzi for a form of bladder cancer. Read More
(Alliance News) - United Utilities leaves its financial guidance for 2027 unchanged, while Harworth backs an increased takeover offer from Peel Holdings. Meanwhile, Iran proposes a seven-day plan to reopen the Strait of Hormuz and restart talks with the US. Read More
(Alliance News) - AstraZeneca PLC on Wednesday said the EU approved Trixeo Aerosphere for the maintenance treatment of asthma. Read More
(Alliance News) - Airtel Africa's mobile money business plans what could be one of London's biggest IPOs in recent years. JD Sports reports a sharp fall in adjusted first-half profit but maintains its annual guidance, while Diageo appoints WPP's Joanne Wilson as its new chief financial officer. Read More
(Alliance News) - The FTSE 100 fell heavily on Friday as bond yields pushed higher amid fears that higher inflation will keep interest rates elevated. Read More
(Alliance News) - AstraZeneca PLC on Friday announced that Klygefa has been recommended for approval in the EU, as a treatment for generalised myasthenia gravis. Read More
(Alliance News) - AstraZeneca PLC and its partner Daiichi Sankyo Co Ltd on Friday announced that their cancer drug Enhertu has been recommended to be approved in the EU for a form of breast cancer. Read More
(Alliance News) - Stock prices in London were mixed at midday on Friday, with the FTSE 100 weighed down by steep losses for Airtel Africa. Read More
AstraZeneca PLC - Cambridge, England-based pharmaceutical company - Chief Executive Officer Pascal Soriot buys 60,000 shares at GBP121.02, worth GBP7.3 million, on Monday in London. Read More
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More